ICI-based treatment as first-line therapy improves outcomes in patients with nccRCC
Recent real-world data to support the use of ICI-based or VEGF-TKI treatment as first-line therapy in patients with nccRCC.
Recent real-world data to support the use of ICI-based or VEGF-TKI treatment as first-line therapy in patients with nccRCC.